To verify the strong cytotoxic effect as a benefit of repetitive ECT, immunocytochemical staining for Ki67 (marker of proliferating cells) and cParp-1 (marker of apoptotic cells) was performed on cross sections of tumor spheroids after 7 days of treatment. This evidence concerns the gene MKI67 and neoplasm.